FOVEA PHARMACEUTICALS COMPLETES A EUR 20.5 MILLION ($25 MILLION) SERIES A FINANCING

Fovea Pharmaceuticals SA (Fovea), a biopharmaceutical company created in May 2005 by a team of experienced scientists and managers, announced today the closing of a EUR20.5 million ($25 million) equity financing round. The international syndicate was led by Sofinnova Partners (France) and includes Abingworth Management (UK), The Wellcome Trust (UK), GIMV (Belgium) and Credit Agricole Private Equity (France).
PR Newswire